The global women’s health market was valued at USD 35.02 billion In 2019 and is expected to grow to around USD 41.05 billion by 2027, showing a steady growth rate of 3.2% during the forecast period. That same year, North America led the market, accounting for over half (51.4%) of the global share.

The market is growing mainly due to the increasing number of health issues that specifically affect women—such as osteoporosis, breast cancer, and menopause-related conditions. For example, according to the World Health Organization (WHO), breast cancer is the most common cancer among women, affecting 2.1 million women every year, and is responsible for about 15% of all cancer-related deaths in women. To meet this rising demand, many companies are expanding their reach by launching new products, forming partnerships, and organizing awareness campaigns. One example is Ziqitza Healthcare, which in March 2020 ran a Corporate Wellness Program aimed at helping women employees improve their health and overall productivity.

Request a Free Sample PDF:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/women-s-health-market-101847

Women’s Health Market Trend:

The Women’s Health Market is evolving as greater attention is being placed on gender-specific healthcare needs. A major trend is the rising demand for personalized and preventive care—driven by growing awareness around conditions like osteoporosis, menopause, breast cancer, and reproductive health. There’s also increasing investment in digital health platforms and wearable tech focused specifically on women’s health, including fertility tracking and hormonal monitoring. Telehealth services are becoming more common, offering convenience and improving access, especially for women in remote or underserved areas.

Women’s Health Market Growth:

The Women’s Health Market is growing steadily, thanks to increasing awareness, education, and proactive approaches to health among women globally. Governments and private organizations are investing more in programs and research focused on women's health issues, leading to improved diagnosis and treatment options. A growing aging female population, combined with rising cases of lifestyle-related conditions, is also contributing to market growth. Additionally, the introduction of innovative drugs and medical devices tailored to women's health needs is fueling demand across different healthcare segments.

List Of Key Companies Profiled:

• Bayer AG (Leverkusen, Germany)

• Pfizer Inc. (New York, United States)

• Amgen Inc. (California, United States)

• Novartis AG (Basel, Switzerland)

• Merck & Co., Inc. (New Jersey, United States)

• Eli Lilly and Company (Indiana, United States)

• LUPIN (Mumbai, India)

• AstraZeneca (Cambridge, United Kingdom)

• Agile Therapeutics (New Jersey, United States)

• Other Prominent Players

Women’s Health Market Segmentation:

The Women’s Health Market can be segmented based on product type, application, age group, and end-user.

By product type, the Women’s Health Market includes pharmaceuticals, diagnostics, devices, and wellness products. Pharmaceuticals dominate this segment, with hormone therapies, contraceptives, and osteoporosis drugs leading the charge. Diagnostic tools, especially for breast and cervical cancer screening, are also seeing strong growth as early detection becomes a top priority.

In terms of application, the Women’s Health Market covers areas such as reproductive health, bone health, menopause, breast cancer, urinary incontinence, and mental health. Reproductive health continues to be the largest segment, driven by growing demand for fertility treatments, birth control, and maternal care. Meanwhile, rising awareness around menopause management and hormone therapy is expanding that segment as well.

By age group, the Women’s Health Market is segmented into adolescents, adults, and older women. While all groups are important, healthcare needs vary widely. Younger women are typically focused on contraception and reproductive health, adults on pregnancy and menstrual health, and older women on menopause, bone density, and chronic disease management.

From an end-user perspective, the Women’s Health Market serves hospitals, specialty clinics, home healthcare, and diagnostic centers. Hospitals and specialty clinics are the primary users, offering a full range of services from diagnostics to treatment. However, home healthcare services and wellness centers are growing in popularity, particularly for managing chronic conditions and providing personalized care.

Women’s Health Market Restraining Factors:

Despite progress, the Women’s Health Market faces several challenges. Limited access to quality healthcare in low- and middle-income regions remains a major barrier. Social stigma and lack of awareness around certain health issues—especially related to reproductive and mental health—can hinder women from seeking timely care. Another limiting factor is the underrepresentation of women in clinical trials, which can slow down the development of effective, gender-specific treatments. Additionally, pricing pressures and regulatory hurdles can delay the launch of new products in the market.

Women’s Health Market Regional Analysis:

Regionally, North America leads the Women’s Health Market due to strong healthcare infrastructure, high awareness, and continuous innovation. Europe follows closely with an aging population and supportive government health initiatives focused on women. The Asia-Pacific region is expected to witness the fastest growth, driven by increasing healthcare investments, rising awareness, and improving access to medical services. Latin America and the Middle East & Africa are also gradually expanding, thanks to initiatives aimed at improving maternal health and reducing gender disparities in healthcare access.

Key Industry Developments:

• June 2021 – Organon made its debut on the New York Stock Exchange as the only global company focused solely on women’s health. The company aims to tackle some of the biggest challenges in women’s healthcare, with a strong focus on reproductive health and other female-specific conditions.

• May 2021 – Probi partnered with Tervisetehnoloogiate Arenduskeskus through a research and development agreement to create new probiotic products. The collaboration is centered on using lactobacilli strains to support and improve vaginal health.

 Contact us:
Fortune Business Insights™ Pvt.
Phone: USA: +1 833 909 2966 (Toll-Free),
United Kingdom: +44 808 502 0280 (Toll-Free)
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com